Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rejuvenate Muscle Activator is a patented, plant-based dietary supplement formulated to support muscle building and maintenance. It contains a clinically optimized blend of all essential amino acids (EAAs), designed for rapid absorption and immediate support of muscle protein synthesis. Each serving delivers 3.6g of EAAs with only 5 calories, providing the muscle-building benefits equivalent to 40g of whey protein isolate but without fat, sugar, or carbohydrates. The product is especially targeted at older adults experiencing age-related muscle loss (sarcopenia), bariatric patients needing efficient protein intake post-surgery, and individuals seeking improved recovery after exercise or illness. Developed over more than 17 years with at least 25 clinical trials supporting its efficacy, it has been shown to increase muscle protein synthesis by up to 57%, outperforming traditional whey protein supplements[1][2][3][4][5][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Rejuvenate Muscle Activator.